In 2025, the spotlight is on neurodegenerative drug development, driven by the triumph of Lecanemab and Donanemab, coupled with rapid advancements to enable presymptomatic diagnosis, reinvigorating the space with new targets, modalities, and technologies. Meanwhile significant advancements to target the likes of α-synuclein, NLRP3 and GBA suggest only a matter of time until a disease-modifying therapy emerges on the scene for Parkinson’s too.

At Johns Hopkins, experts across various disciplines have come together to achieve a new level of precision in health care. Combining the knowledge of specialists from one of the world’s pre-eminent academic medical centers, renowned public health scholars and some of the best systems engineers on planet - Johns Hopkins in Health is continuing to explore and develop precision medicine approaches that will lead to quicker diagnoses, improved treatment and better outcomes. Johns Hopkins School of Medicine was awarded $335M from the National Institutes of Health in 2017.

The prestigious Bionow Awards Dinner is a highlight of the life sciences calendar and celebrates the achievements of the sector, showcasing the very best. Invite your colleagues and clients for an unforgettable evening dining beneath the iconic Concorde, which takes pride of place in the super hangar. Grab a glass of bubbles, take a tour and imagine you’re travelling at the speed of sound to New York!

Join Bionow to mark this occasion in style - pop open the champagne and celebrate the award nominees and winners with us!

“Networking's horrible, isn’t it? And you have to do it promote your business. However, I believe that the right approach can be effective and enjoyable. In my talk, I will share some gems of wisdom on how to make genuine connections with people the kind that might lead to actually getting some work.” Cambridge Network is delighted to say that Jon Torrens will be repeating his recent oversubscribed session on how to network, on 6th March. 

Jon says: “In this session I will cover: